Abstract The coronavirus-2019 (COVID-19) infection pandemic has affected the care of
patients with heart failure (HF) who have contracted COVID-19 as well as those without …

Heart failure is a leading cause of death worldwide. While there are multiple etiologies
contributing to the development of heart failure, all cause result in impairments in cardiac …

Background Patients with pre-existing heart failure (HF) are likely at higher risk for adverse
outcomes in coronavirus disease-2019 (COVID-19), but data on this population are sparse …

Cardiomyopathies (CMPs) represent a diverse group of heart muscle diseases, grouped into
specific morphological and functional phenotypes. CMPs are associated with mutations in …

In kidney disease (KD), several factors released into the bloodstream can induce a series of
changes in the heart, leading to a wide variety of clinical situations called cardiorenal …

Background: GlycA, a nuclear magnetic resonance composite marker of systemic
inflammation, reflects serum concentration and glycosylation state of main acute phase …

Radix Aconiti Lateralis Preparata (Fuzi) is a traditional Chinese medicine. Its alkaloids are
both cardiotonic and cardiotoxic; however, the underlying mechanisms are unclear …

Helichrysum stoechas has been conventionally used as herbal tea due to its anti-
inflammatory, antioxidant, antimicrobial and diuretic activities. Ethanolic extract of the aerial …

Objective: C-Reactive Protein (CRP) has emerged as an accessible measured product of
inflammation. Whether systemic inflammation, a common feature of Heart Failure (HF), can …

Even if cancer and cardiovascular diseases are considered two distinct diseases, an
intricate interconnection between these conditions has been established. Increased risk of …